newsfilter
← Latest News
PR Newswire·

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

FORT COLLINS, Colo., Aug. 16, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ:CBLI), a leading biopharmaceutical company creating next-generation immune therapies for serious medical conditions that induce immune restoration and homeostasis, today reported